Investor Calendar

Investor Calendar

Upcoming Events
Jun 1 - June 5, 2018
  • Abstract Titles:
    • Overall Survival of PEGylated Pegilodecakin with 5-FU/LV and Oxaliplatin (FOLFOX) in Metastatic Pancreatic Adenocarcinoma (PDAC)
    • Responses and Durability in NSCLC Treated with Pegilodecakin and anti-PD-1
    • Pegilodecakin with Nivolumab (nivo) or pembrolizumab (pembro) in Patients with Metastatic Renal Cell Carcinoma (RCC)